ECD Proteins
SKU: PME101370 Target: BCMA
Price: 10μg $75.00; 50μg $259.00 ; 100μg $389.00
ECD Proteins
SKU: PME101371 Target: BCMA
Price: 10μg $75.00; 50μg $259.00 ; 100μg $389.00
ECD Proteins
SKU: PME101369 Target: BCMA
Price: 10μg $79.00; 50μg $281.00 ; 100μg $422.00
ECD Proteins
SKU: PME101368 Target: BCMA
Price: 10μg $75.00; 50μg $259.00 ; 100μg $389.00
ECD Proteins
SKU: PME101367 Target: BCMA
Price: 10μg $79.00; 50μg $281.00 ; 100μg $422.00
ECD Proteins
SKU: PME100001 Target: BCMA
Price: 10μg $82.00; 50μg $320.00 ; 100 μg $480.00
ECD Proteins
SKU: PME100035 Target: BCMA
Price: 10μg $96.00; 50μg $370.00 ; 100 μg $555.00
ECD Proteins
SKU: PME-M100001 Target: BCMA
Price: 10μg $78.00; 50μg $310.00 ; 100 μg $460.00
ECD Proteins
SKU: PME100511 Target: BCMA
Price: 10μg $91.00; 50μg $348.00 ; 100 μg $522.00
ECD Proteins
SKU: PME-C100060 Target: BCMA
Price: 10μg $100.00; 50μg $358.00 ; 100 μg $528.00
Posts found
Advances in Targeting B-Cell Maturation Antigen (BCMA) for Non-Invasive Imaging and Therapy in Multiple Myeloma
Recent advancements in the field of nuclear medicine have highlighted the significance of B-Cell Maturation [...]
Oct
Research Progress on BCMA-Targeted Therapies in Multiple Myeloma
On August 27, 2024, Legend Biotech’s BCMA CAR-T product, Carvykti® (generic name: ciltacabtagene autoleucel injection), [...]
Sep
Research Progress on Targeting BCMA in Autoimmune Diseases
The B cell maturation antigen (BCMA), a target that gained prominence due to its association [...]
Aug
Who Dominates the Billion-Dollar Market for Systemic Lupus Erythematosus Treatment?
According to a blog released by market intelligence provider Future Market Insights, Inc. (FMI) on [...]
Sep
Discover DIMA at Membrane Protein Paris 2024
Membrane proteins are essential for cell functions such as maintaining cellular physiological processes, playing crucial [...]
Understanding Single B Cell Cloning Technology in One Read
Antibody drugs, due to their high specificity and significant therapeutic effects, possess superior pharmacokinetic properties, [...]
Feb
A Look Back: FDA Approval of Monoclonal Antibodies in 2023
As of December 31, 2023, the FDA records that a total of 55 new drugs were approved in [...]
Jan
2023 ASH | Exploring Advances in Clinical Research on GPRC5D Targeted Drugs
GPRC5D, identified as a G protein-coupled orphan receptor, demonstrates limited expression in normal tissues.
Jan
Unraveling the Mystery of ‘Million-Dollar’ CAR-T Therapy
In 2012, a young girl named Emily Whitehead, suffering from acute lymphoblastic leukemia, became the [...]
Oct
Unlocking the Potential of Mammalian Cell Display in Antibody Drug Innovation
In 1986, the world’s first monoclonal therapeutic drug, Orthoclone (OKT3), was approved by the FDA [...]
Sep